IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+0.65%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$560M
AUM Growth
+$560M
Cap. Flow
-$113M
Cap. Flow %
-20.13%
Top 10 Hldgs %
31.32%
Holding
256
New
15
Increased
27
Reduced
52
Closed
40

Top Buys

1
BIIB icon
Biogen
BIIB
$41.6M
2
CRSP icon
CRISPR Therapeutics
CRSP
$16.9M
3
ALEC icon
Alector
ALEC
$8.69M
4
CGEM icon
Cullinan Oncology
CGEM
$7.59M
5
CCXI
ChemoCentryx, Inc.
CCXI
$6.31M

Top Sells

1
LLY icon
Eli Lilly
LLY
$27.4M
2
IMAB
I-MAB
IMAB
$17.1M
3
TPST icon
Tempest Therapeutics
TPST
$14.1M
4
CRIS icon
Curis
CRIS
$13.8M
5
PRTA icon
Prothena Corp
PRTA
$11M

Sector Composition

1 Healthcare 96.31%
2 Technology 0.53%
3 Consumer Staples 0.24%
4 Financials 0.14%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TARA icon
26
Protara Therapeutics
TARA
$124M
$5.7M 0.46%
584,804
-64,738
-10% -$631K
VSTM icon
27
Verastem
VSTM
$561M
$5.68M 0.46%
1,394,394
-1,300,000
-48% -$5.29M
VINC
28
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$5.54M 0.45%
426,743
-11,941
-3% -$155K
CMMB
29
Chemomab Therapeutics
CMMB
$15.8M
$5.53M 0.45%
+290,534
New +$5.53M
STTK icon
30
Shattuck Labs
STTK
$61.3M
$5.52M 0.45%
190,330
– –
HZNP
31
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.13M 0.42%
54,815
+54,212
+8,990% +$5.08M
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$4.3B
$5.12M 0.41%
209,866
+203,858
+3,393% +$4.97M
LYRA icon
33
Lyra Therapeutics
LYRA
$11.8M
$5.02M 0.41%
624,684
-156,044
-20% -$1.25M
FNCH
34
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$4.57M 0.37%
325,000
+175,000
+117% +$2.46M
IOVA icon
35
Iovance Biotherapeutics
IOVA
$792M
$4.55M 0.37%
+175,000
New +$4.55M
STSA
36
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$4.54M 0.37%
644,056
-32,238
-5% -$227K
OVID icon
37
Ovid Therapeutics
OVID
$93.2M
$4.4M 0.36%
1,124,872
– –
CHAQ.U
38
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$4.37M 0.35%
400,000
– –
NXTC icon
39
NextCure
NXTC
$13.1M
$4.15M 0.34%
516,870
+62,918
+14% +$505K
IMAB
40
I-MAB
IMAB
$372M
$3.87M 0.31%
46,066
-203,934
-82% -$17.1M
ARKG icon
41
ARK Genomic Revolution ETF
ARKG
$1.04B
$3.79M 0.31%
40,961
+38,961
+1,948% +$3.6M
RDNT icon
42
RadNet
RDNT
$5.42B
$3.73M 0.3%
+110,647
New +$3.73M
KDMN
43
DELISTED
Kadmon Holdings, Inc.
KDMN
$3.63M 0.29%
936,615
– –
DBVT
44
DBV Technologies
DBVT
$257M
$3.55M 0.29%
322,730
– –
RNTX
45
Rein Therapeutics, Inc. Common Stock
RNTX
$30.2M
$3.5M 0.28%
2,800,000
– –
PHAT icon
46
Phathom Pharmaceuticals
PHAT
$844M
$3.39M 0.27%
100,000
– –
TCDA
47
DELISTED
Tricida, Inc. Common Stock
TCDA
$3.35M 0.27%
775,294
– –
SYBX icon
48
Synlogic
SYBX
$17.2M
$3.3M 0.27%
848,354
-644,260
-43% -$2.51M
FOLD icon
49
Amicus Therapeutics
FOLD
$2.41B
$3.29M 0.27%
341,500
– –
CMPS
50
Compass Pathways
CMPS
$451M
$3.25M 0.26%
85,063
-140,863
-62% -$5.37M
1
2
3 4 5